Work

The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS‐CoV‐2 infection

Year: 2022

Type: article

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel subset of coronavirus that causes coronavirus disease 2019 (COVID-19), but vaccine development is hampered by the high mutation of virus This article is protected by copyright. All rights reserved.

Source: Journal of Medical Virology

DOI: 10.1002/jmv.28359

Authors: Deyan Luo, Tao Li, Xiaolan Yang, Nianzhi Ning, Liangyan Zhang, Hongjing Gu, Deyu Li, Wenjing Yu, Zhongyu Hu, Hui Wang

Institutions: Beijing Institute of Microbiology and Epidemiology, National Institutes for Food and Drug Control

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4310467707

FWCI: 0.61

Cites: 7

Cited by: 6

Related to: 10